EU approved AstraZeneca’s Forxiga for heart failure

The FINANCIAL — AstraZeneca’s Forxiga (dapagliflozin) has been approved in the European Union (EU) for the treatment of symptomatic chronic heart failure with reduced ejection fraction (HFrEF) in adults with and without type-2 diabetes (T2D). Heart failure (HF) is a life-threatening chronic disease that…

4 mins read

Apple won appeal over €13 billion against EU

The FINANCIAL — The General Court of the European Union issued its judgment in the Apple State Aid case today (Wednesday 15 July 2020) annulling the European Commission Decision. In 2016 The European Commission concluded that Ireland granted undue tax benefits of up to…

5 mins read